
MLLCF
Healthcare · Biotechnology · $153.7M market cap
$4.010.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 4, 2026 | Before the open | — | -0.42 | — |
| Aug 25, 2025 | Before the open | — | -0.66 | — |
| Mar 6, 2025 | After the close | — | -0.35 | — |
| Nov 1, 2024 | Before the open | — | -0.57 | — |
| Aug 26, 2024 | After the close | — | -0.50 | — |
| Mar 15, 2024 | Before the open | — | -0.68 | — |
| Mar 9, 2023 | After the close | — | -0.50 | — |
| Oct 27, 2022 | After the close | — | -0.42 | — |
| Aug 9, 2022 | Before the open | — | -0.14 | — |
| May 12, 2022 | After the close | — | 5.00 | — |
| Mar 15, 2022 | After the close | — | -0.60 | — |
| Oct 28, 2021 | Before the open | -0.55 | -0.38 | +30.9% |
| Aug 25, 2021 | After the close | -0.57 | -0.41 | +28.2% |
| May 3, 2021 |
Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute…
| After the close |
| — |
| -0.61 |
| — |
| Feb 4, 2021 | After the close | -0.61 | -0.60 | +1.5% |
| Dec 31, 2020 | Time not confirmed | 0.00 | -0.76 | — |
| Aug 25, 2020 | After the close | 0.28 | -0.65 | -333.0% |
| Jun 30, 2020 | Time not confirmed | 0.00 | -0.55 | — |
| Feb 12, 2020 | Before the open | 0.00 | -0.64 | — |
| Dec 31, 2019 | Time not confirmed | 0.00 | -0.57 | — |
| Aug 26, 2019 | After the close | 0.00 | -0.55 | — |
| May 8, 2019 | After the close | 0.00 | -0.31 | — |
| Feb 6, 2019 | After the close | 0.00 | -0.30 | — |
| Dec 31, 2018 | Time not confirmed | 0.00 | -0.61 | — |
| Aug 29, 2018 | After the close | 0.00 | -0.61 | — |
| Jun 30, 2018 | Time not confirmed | 0.00 | -0.28 | — |
| Feb 12, 2018 | After the close | 0.00 | -0.29 | — |